353 related articles for article (PubMed ID: 34168650)
21. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
Pinto AK; Jamieson AM; Raulet DH; Hill AB
J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
[TBL] [Abstract][Full Text] [Related]
22. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
[TBL] [Abstract][Full Text] [Related]
23. Investigating the Dynamics of MCMV-Specific CD8
Gabel M; Baumann NS; Oxenius A; Graw F
Front Immunol; 2019; 10():1358. PubMed ID: 31281313
[TBL] [Abstract][Full Text] [Related]
24. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
Arapovic J; Lenac T; Antulov R; Polic B; Ruzsics Z; Carayannopoulos LN; Koszinowski UH; Krmpotic A; Jonjic S
J Virol; 2009 Aug; 83(16):8198-207. PubMed ID: 19494006
[TBL] [Abstract][Full Text] [Related]
25. NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase.
Wensveen FM; Lenartic M; Jelencic V; Lemmermann NA; ten Brinke A; Jonjic S; Polic B
J Immunol; 2013 Aug; 191(3):1307-15. PubMed ID: 23804716
[TBL] [Abstract][Full Text] [Related]
26. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
[TBL] [Abstract][Full Text] [Related]
27. Optimal CD8
Dimonte S; Gimeno-Brias S; Marsden M; Chapman L; Sabberwal P; Clement M; Humphreys IR
Immunology; 2021 Oct; 164(2):279-291. PubMed ID: 34003499
[TBL] [Abstract][Full Text] [Related]
28. Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8
Liu J; Jaijyan DK; Tang Q; Zhu H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510028
[TBL] [Abstract][Full Text] [Related]
29. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system.
Alonso-Arias R; Moro-García MA; López-Vázquez A; Rodrigo L; Baltar J; García FM; Jaurrieta JJ; López-Larrea C
Age (Dordr); 2011 Dec; 33(4):591-605. PubMed ID: 21210234
[TBL] [Abstract][Full Text] [Related]
30. MCMV avoidance of recognition and control by NK cells.
Brizić I; Lenac Roviš T; Krmpotić A; Jonjić S
Semin Immunopathol; 2014 Nov; 36(6):641-50. PubMed ID: 25141793
[TBL] [Abstract][Full Text] [Related]
31. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine.
McLaren JE; Clement M; Marsden M; Miners KL; Llewellyn-Lacey S; Grant EJ; Rubina A; Gimeno Brias S; Gostick E; Stacey MA; Orr SJ; Stanton RJ; Ladell K; Price DA; Humphreys IR
J Immunol; 2019 Feb; 202(3):943-955. PubMed ID: 30635396
[TBL] [Abstract][Full Text] [Related]
32. Early primed KLRG1- CMV-specific T cells determine the size of the inflationary T cell pool.
Baumann NS; Welten SPM; Torti N; Pallmer K; Borsa M; Barnstorf I; Oduro JD; Cicin-Sain L; Oxenius A
PLoS Pathog; 2019 May; 15(5):e1007785. PubMed ID: 31083700
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi Infection.
Vasconcelos JR; Dominguez MR; Neves RL; Ersching J; Araújo A; Santos LI; Virgilio FS; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
Hum Gene Ther; 2014 Apr; 25(4):350-63. PubMed ID: 24568548
[TBL] [Abstract][Full Text] [Related]
34. Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection.
Beyranvand Nejad E; Ratts RB; Panagioti E; Meyer C; Oduro JD; Cicin-Sain L; Früh K; van der Burg SH; Arens R
J Immunother Cancer; 2019 Jan; 7(1):25. PubMed ID: 30704520
[TBL] [Abstract][Full Text] [Related]
35. Tcf1
Welten SPM; Yermanos A; Baumann NS; Wagen F; Oetiker N; Sandu I; Pedrioli A; Oduro JD; Reddy ST; Cicin-Sain L; Held W; Oxenius A
Nat Commun; 2020 May; 11(1):2295. PubMed ID: 32385253
[TBL] [Abstract][Full Text] [Related]
36. gB co-immunization with GP96 enhances pulmonary-resident CD8 T cells and exerts a long-term defence against MCMV pneumonitis.
Guo B; Xu P; Chai D; Cao L; Liu L; Song T; Hu S; Chen Y; Yan X; Xu T
J Cell Mol Med; 2020 Dec; 24(24):14426-14440. PubMed ID: 33155438
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
[TBL] [Abstract][Full Text] [Related]
38. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation.
Torti N; Walton SM; Murphy KM; Oxenius A
Eur J Immunol; 2011 Sep; 41(9):2612-8. PubMed ID: 21604258
[TBL] [Abstract][Full Text] [Related]
39. Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.
Dekhtiarenko I; Ratts RB; Blatnik R; Lee LN; Fischer S; Borkner L; Oduro JD; Marandu TF; Hoppe S; Ruzsics Z; Sonnemann JK; Mansouri M; Meyer C; Lemmermann NA; Holtappels R; Arens R; Klenerman P; Früh K; Reddehase MJ; Riemer AB; Cicin-Sain L
PLoS Pathog; 2016 Dec; 12(12):e1006072. PubMed ID: 27977791
[TBL] [Abstract][Full Text] [Related]
40. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response.
Gold MC; Munks MW; Wagner M; McMahon CW; Kelly A; Kavanagh DG; Slifka MK; Koszinowski UH; Raulet DH; Hill AB
J Immunol; 2004 Jun; 172(11):6944-53. PubMed ID: 15153514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
